Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction
出版年份 2012 全文链接
标题
Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction
作者
关键词
-
出版物
Cardiovascular Diabetology
Volume 11, Issue 1, Pages 125
出版商
Springer Nature
发表日期
2012-10-11
DOI
10.1186/1475-2840-11-125
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Statin Use and Risk of Diabetes Mellitus in Postmenopausal Women in the Women's Health Initiative
- (2012) Annie L. Culver ARCHIVES OF INTERNAL MEDICINE
- Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease
- (2012) Rajesh Chaudhary et al. Cardiovascular Diabetology
- Effects of bezafibrate on lipid and glucose metabolism in dyslipidemic patients with diabetes: the J-BENEFIT study
- (2012) Tamio Teramoto et al. Cardiovascular Diabetology
- Association Between Omega-3 Fatty Acid Supplementation and Risk of Major Cardiovascular Disease Events
- (2012) Evangelos C. Rizos et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- High-Density Lipoprotein Cholesterol and Particle Concentrations, Carotid Atherosclerosis, and Coronary Events
- (2012) Rachel H. Mackey et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular Events in Patients Received Combined Fibrate/Statin Treatment versus Statin Monotherapy: Acute Coronary Syndrome Israeli Surveys Data
- (2012) Alexander Tenenbaum et al. PLoS One
- Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial
- (2011) Russell Scott et al. Cardiovascular Diabetology
- "The metabolic syndrome... is dead": These reports are an exaggeration
- (2011) Alexander Tenenbaum et al. Cardiovascular Diabetology
- Serum Non-high-density lipoprotein cholesterol concentration and risk of death from cardiovascular diseases among U.S. adults with diagnosed diabetes: the Third National Health and Nutrition Examination Survey linked mortality study
- (2011) Chaoyang Li et al. Cardiovascular Diabetology
- Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence
- (2011) Michel P Hermans et al. Cardiovascular Diabetology
- Cardiometabolic risk variables in overweight and obese children: a worldwide comparison
- (2011) Mariska van Vliet et al. Cardiovascular Diabetology
- Estimated incidence of cardiovascular complications related to type 2 diabetes in Mexico using the UKPDS outcome model and a population-based survey
- (2011) Nancy Reynoso-Noverón et al. Cardiovascular Diabetology
- Predicting insulin resistance using the triglyceride-to-high-density lipoprotein cholesterol ratio in Taiwanese adults
- (2011) Jui-Kun Chiang et al. Cardiovascular Diabetology
- Triglycerides and Cardiovascular Disease
- (2011) Michael Miller et al. CIRCULATION
- Optimal pharmacotherapy to combat the atherogenic lipid triad
- (2011) M. John Chapman et al. CURRENT OPINION IN CARDIOLOGY
- Non-invited Review: Prevention of microvascular diabetic complications by fenofibrate: lessons from FIELD and ACCORD
- (2011) Michel P Hermans Diabetes & Vascular Disease Research
- "If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study
- (2010) Alexander Tenenbaum et al. Cardiovascular Diabetology
- Comparative Study of Bezafibrate and Pravastatin in Patients With Coronary Artery Disease and High Levels of Remnant Lipoprotein
- (2010) Keita Sano et al. CIRCULATION JOURNAL
- High-Density Lipoprotein and Coronary Heart Disease
- (2010) Pradeep Natarajan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Metabolic Syndrome and Cardiovascular Risk
- (2010) Salvatore Mottillo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
- (2010) Min Jun et al. LANCET
- Long-term Benefit of High-Density Lipoprotein Cholesterol–Raising Therapy With Bezafibrate
- (2009) Ilan Goldenberg et al. ARCHIVES OF INTERNAL MEDICINE
- Antidiabetic Action of Bezafibrate in a Large Observational Database
- (2009) J. H. Flory et al. DIABETES CARE
- Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: The National Health and Nutrition Examination Survey 2003-2004
- (2008) Heli Ghandehari et al. AMERICAN HEART JOURNAL
- The Residual Risk Reduction Initiative: A Call to Action to Reduce Residual Vascular Risk in Patients with Dyslipidemia
- (2008) Jean-Charles Fruchart et al. AMERICAN JOURNAL OF CARDIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started